RTK class III

RTK class III is a class of receptor tyrosine kinases.It includes PDGFRα, PDGFRβ, C-KIT, CSF1R, and FLT3.[1]
receptor tyrosine kinasesPDGFRαPDGFRβProtein kinasestyrosine kinasesGrowth factor receptorsEGF receptor familyInsulin receptorPDGFRAPDGFRBFGF receptorVEGF receptorsVEGFR1VEGFR2VEGFR3HGF receptorTrk receptorEPH receptorLTK receptorTIE receptorROR receptorDDR receptorPTK7 receptorRYK receptorMuSK receptorAATYK receptorAATYK2AXL receptorRET receptorNon-receptor tyrosine kinasesEnzymesActive siteBinding siteCatalytic triadOxyanion holeEnzyme promiscuityDiffusion-limited enzymeCofactorEnzyme catalysisAllosteric regulationCooperativityEnzyme inhibitorEnzyme activatorEC numberEnzyme superfamilyEnzyme familyList of enzymesEnzyme kineticsEadie–Hofstee diagramHanes–Woolf plotLineweaver–Burk plotMichaelis–Menten kineticsOxidoreductasesTransferasesHydrolasesLyasesIsomerasesLigasesTranslocasesGrowth factor receptormodulatorsAngiopoietinAngiopoietin 1Angiopoietin 4Angiopoietin 2RebastinibEvinacumabNesvacumabAxokineEGF (ErbB)EGF(ErbB1/HER1)AmphiregulinBetacellulinEGF (urogastrone)EpigenEpiregulinHeparin-binding EGF-like growth factor (HB-EGF)MuroderminNepiderminTransforming growth factor alpha (TGFα)AfatinibBrigatinibCanertinibDacomitinibErlotinibGefitinibGrandininIcotinibLapatinibNeratinibOsimertinibVandetanibCetuximabDepatuxizumab mafodotinFutuximabImgatuzumabMatuzumabNecitumumabNimotuzumabPanitumumabZalutumumabErbB2/HER2ErtumaxomabPertuzumabTrastuzumabTrastuzumab deruxtecanTrastuzumab emtansineMubritinibTucatinibErbB3/HER3Neuregulins (heregulins)6 (neuroglycan C)DuligotumabPatritumabSeribantumabErbB4/HER42 (bFGF)10 (KGF2)SelpercatinibTraferminPaliferminSpriferminInfigratinibBurosumabFGF15/19HGF (c-Met)FosgonimetonHepatocyte growth factorDihexa (PNB-0408)CabozantinibCapmatinibCrizotinibForetinibTivantinibVolitinibEmibetuzumabFiclatuzumabFlanvotumabOnartuzumabRilotumumabTelisotuzumab vedotindes(1-3)IGF-1Insulin-like growth factor-1 (somatomedin C)IGF-1 LR3Insulin-like growth factor-2 (somatomedin A)InsulinMecaserminMecasermin rinfabateLinsitinibCixutumumabDalotuzumabFigitumumabGanitumabRobatumumabTeprotumumabDusigitumabTrofinetideLNGF (p75NTR)BNN-20BNN-27CenegerminDHEA-SDexamethasoneTestosteroneFasinumabFrunevetmabFulranumabTanezumabBecaplerminPlatelet-derived growth factorAvapritinibAxitinibCrenolanibImatinibLenvatinibMasitinibMotesanibNintedanibPazopanibRadotinibQuizartinibRipretinibSunitinibSorafenibToceranibOlaratumabRamucirumabTovetumabRET (GFL)GFRα1Glial cell line-derived neurotrophic factor (GDNF)GFRα2Neurturin (NRTN)GFRα3Artemin (ARTN)GFRα4Persephin (PSPN)SCF (c-Kit)AncestimStem cell factorDasatinibNilotinibAmitriptylineTavilermideEntrectinibLarotrectinibLestaurtinib4'-DMA-7,8-DHF7,8-DHF7,8,3'-THFDeoxygeduninDeprenylDiosmetinLM22A-4N-AcetylserotoninNorwogonin (5,7,8-THF)ANA-12Cyclotraxin BGossypetin (3,5,7,8,3',4'-HHF)Placental growth factor (PGF)D (FIGF)CediranibFruquintinibPegaptanibRegorafenibSemaxanibTivozanibAlacizumab pegolBevacizumabIcrucumabRanibizumabAfliberceptAdrenomedullinColony-stimulating factorsConnective tissue growth factor (CTGF)EphrinsErythropoietinGlucose-6-phosphate isomerase (GPI; PGI, PHI, AMF)Glia maturation factor (GMF)Hepatoma-derived growth factor (HDGF)InterleukinsT-cell growth factorsLeukemia inhibitory factor (LIF)Macrophage-stimulating protein (MSP; HLP, HGFLP)Midkine (NEGF2)Migration-stimulating factor (MSF; PRG4)OncomodulinPituitary adenylate cyclase-activating peptide (PACAP)PleiotrophinRenalaseThrombopoietinWnt signaling proteinsCerebrolysin